Periodic Reporting for period 1 - ENHANCIDO (Commercialization of catalytic enhancers targeting IDO1 for multiple sclerosis)

Multiple sclerosis (MS) is a chronic and progressive neurodegenerative disease impacting the central nervous system occurring when the immune system attacks nerve fibers and myelin sheathing in the brain and spinal cord. MS represents a substantial worldwide economic burden...